Work

Long-Term Efficacy and Safety of Deferasirox (Exjade®, ICL670), a Once-Daily Oral Iron Chelator, in Patients with Sickle Cell Disease (SCD).

Year: 2007

Type: article

Source: Blood

DOI: 10.1182/blood.v110.11.3395.3395

Authors: Elliott Vichinsky, Thomas D. Coates, Alexis A. Thompson, Brigitta U. Mueller, Darlene Lagrone, Matthew M. Heeney

Institutions: Children's Hospital Los Angeles, Lurie Children's Hospital, Baylor College of Medicine, Texas Children's Hospital, Novartis (United States), Boston Children's Hospital

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2559580547

FWCI: 0.486

Cites:

Cited by: 5

Related to: 10